Physician profile
Guy T Trono
NPI 1487670071
$5,594.45
in general payments reported to CMS, 2019-2025
46 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $365 · 2021: $693 · 2022: $938 · 2023: $1,139 · 2024: $905 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,200.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $735.30 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $724.38 | 2019-2025 | Xtandi, Myrbetriq |
| Tolmar, INC. | $334.54 | 2023-2025 | Jatenzo |
| Abbvie INC. | $334.39 | 2019-2025 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $331.77 | 2021-2025 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $314.86 | 2020-2023 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $259.74 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $259.22 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $228.79 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $198.97 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $173.75 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $151.94 | 2021-2022 | |
| Janssen Biotech, INC. | $118.64 | 2019-2025 | Erleada |
| Innovation Technologies INC | $114.23 | 2023 | Irrisept |
| Progenics Pharmaceuticals, INC. | $111.71 | 2022-2025 | Pylarify |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $81.47 | 2019 | |
| Teleflex LLC | $80.07 | 2022-2024 | Urolift |
| Agiliti Surgical, INC. | $79.60 | 2023-2024 | Soltive, Trinity, Sonablate |
| Urovant Sciences INC | $77.19 | 2021-2022 | |
| Antares Pharma, INC. | $74.53 | 2024-2025 | Xyosted |
| Urogen Pharma, INC. | $70.75 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $69.62 | 2019 | |
| 180 Medical, INC. | $60.43 | 2019-2025 | |
| Dentsply Ih INC. | $60.24 | 2020-2021 | |
| Axonics, INC. | $57.84 | 2021-2022 | |
| Endo USA, INC. | $48.87 | 2024-2025 | Xiaflex, Aveed |
| Mission Pharmacal Company | $39.35 | 2019-2023 | Uribel |
| C. R. Bard, INC. & Subsidiaries | $39.12 | 2020 | |
| Boston Scientific Corporation | $34.74 | 2021 | |
| Medtronic, INC. | $25.33 | 2023 | Interstim |
| Sun Pharmaceutical Industries INC. | $24.82 | 2023 | Yonsa |
| Halozyme INC | $24.63 | 2023 | |
| Immunitybio, INC. | $24.45 | 2024 | |
| Calyxo, INC. | $24.17 | 2025 | Cvac Aspiration System |
| E.R. Squibb & Sons, L.L.C. | $23.45 | 2023 | Opdivo |
| Hollister Incorporated | $23.09 | 2023 | Vapro, Onli, Infyna Chic |
| Telix Pharmaceuticals | $21.65 | 2025 | Illuccix |
| Olympus America INC. | $19.47 | 2022 | |
| Laborie Medical Technologies Corp. | $19.04 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Alexion Pharmaceuticals, INC. | $17.53 | 2020 | |
| Neotract INC. | $16.36 | 2019 | |
| Allergan, INC. | $15.92 | 2019 | |
| Dentsply Ih Ab | $14.14 | 2021 | |
| Becton, Dickinson and Company | $13.59 | 2024 | Bard Urinary Drainage Bag |
| Metuchen Pharmaceuticals | $12.54 | 2019 | |
| Ambu INC. | $8.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Trono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.